Verastem reported $81.33M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
AbbVie USD 58.94B 4.03B Dec/2025
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
AstraZeneca USD 25.96B 177M Mar/2026
Curis USD 29.43M 10.69M Jun/2024
Cytokinetics USD 247.21M 868.77M Mar/2026
Gilead Sciences USD 20.86B 1.27B Mar/2026
Incyte USD 29.41M 785K Mar/2026
Laboratory Of America USD 5.9B 748.3M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Pfizer USD 60.57B 1.08B Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
TG Therapeutics USD 745.14M 499.5M Mar/2026
Verastem USD 81.33M 31.01M Dec/2025